Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Primegen Biotech
AddedFeb 15, 2024
UpdatedJun 18, 2026
Primegen Biotech

Primegen Biotech

Primegen Biotech LLC: Innovating in stem cell research, specializing in cytokine discovery and in-vitro testing.

HQ
Santa Ana, CA, US
Founded
2002
Overview
Compare
Fundraising
Employees

Primegen Biotech LLC is dedicated to advancing stem cell research, focusing on the discovery of key cytokines, proteins, and other agents. The company specializes in in-vitro testing, growth, activation, and analysis to confirm therapeutic effects in humanized mouse disease models.

Primegen Biotech has made significant strides in biotechnology, contributing to the understanding and application of stem cell therapies. Their innovative research platform has positioned them as a leader in the field, driving advancements in medical treatments and therapeutic discoveries.

Primegen Biotech - Similar Companies

RhinoCyte logo

RhinoCyte

rhinocyte.com

Alpha Genesis logo

Alpha Genesis

Stemgenics logo

Stemgenics

stemgenics.com

Commence Bio logo

Commence Bio

Progenitor Life Sciences logo

Progenitor Life Sciences

Cellebration Life Sciences logo

Cellebration Life Sciences

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

Regenemed logo

Regenemed

regenemed.com

Platelet BioGenesis logo

Platelet BioGenesis

Aruna Bio logo

Aruna Bio

Cyagen Biosciences logo

Cyagen Biosciences

cyagen.com

International Stem Cell logo

International Stem Cell

Personalized Stem Cells logo

Personalized Stem Cells

Transposagen Biopharmaceuticals logo

Transposagen Biopharmaceuticals

Primordial Genetics logo

Primordial Genetics

Primegen Biotech - Quick Facts

Who are Primegen Biotech's competitors?

Companies similar to Primegen Biotech include RhinoCyte, Alpha Genesis, Stemgenics and Commence Bio.

When was Primegen Biotech founded?

Primegen Biotech was founded in 2002.

Where is Primegen Biotech's headquarters located?

Primegen Biotech's headquarters is located in Santa Ana, CA, US.

When was Primegen Biotech's last funding round?

Primegen Biotech's most recent funding round was for $400k (USD) in August 2016.

How much has Primegen Biotech raised to-date?

As of Aug 4, 2016, Primegen Biotech has raised a total of $22.1M (USD).

How many employees does Primegen Biotech have?

Primegen Biotech has 30 employees as of Feb 5, 2024.

Primegen Biotech - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
Customer
  • Enterprise
Main Product
  • Cytokine Discovery
  • Stem Cell Research
Tags
  • Consulting
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified